MULTIRESISTANT-TUMOUR SENSITISER

The present invention relates to the use of the compound Cur-[G-2]-OH as a sensitiser in a wide range of multiresistant tumors, particularly glioblastoma, which are characterised by the overexpression of the Nrf2 pathway. La presente invención se refiere al uso del compuesto Cur-[G-2]-OH como un age...

Full description

Saved in:
Bibliographic Details
Main Author GONZÁLEZ HERRERA, Irma Gabriela
Format Patent
LanguageEnglish
French
Spanish
Published 10.01.2019
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the use of the compound Cur-[G-2]-OH as a sensitiser in a wide range of multiresistant tumors, particularly glioblastoma, which are characterised by the overexpression of the Nrf2 pathway. La presente invención se refiere al uso del compuesto Cur-[G-2]-OH como un agente sensibilizador en una amplia gama de tumores multirresistentes, especialmente el glioblastoma, los cuales se caracterizan por la sobreexpresión de la vía Nrf2. La présente invention concerne l'utilisation du composé Cur-[G-2]-OH en tant qu'agent sensibilisateur dans une vaste variétés de tumeurs multirésistantes, notamment le glioblastome, lesquelles tumeurs sont caractérisées par la surexpression de la voie Nrf2.
Bibliography:Application Number: WO2018MX00065